Evidence map›Paper›PMID 42041290›Full record

ArticleAntibiotics (Basel, Switzerland)2026

Advanced Biosensing Strategies for Last-Line Antibiotics Vancomycin, Colistin, Daptomycin and Meropenem: Comparative Analysis of Electrochemical and Optical Detection Methods.

Vivian Garzon, Daniel G-Pinacho, J-Pablo Salvador, M-Pilar Marco, Rosa-Helena Bustos

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vivian GarzonDoctoral Programme of Biosciences, Universidad de La Sabana, Chía 140013, Cundinamarca, Colombia.
Daniel G-PinachoEvidence-Based Therapeutics Group, Department of Clinical Pharmacology, Faculty of Medicine, Universidad de La Sabana, Campus del Puente del Común, Km. 7, Autopista Norte de Bogotá, Chía 250001, Cundinamarca, Colombia.
J-Pablo SalvadorCentro de Investigación Biomédica en Red en el área Temática de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 08034 Barcelona, Spain.ORCID 0000-0002-3608-0634
M-Pilar MarcoCentro de Investigación Biomédica en Red en el área Temática de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 08034 Barcelona, Spain.ORCID 0000-0002-4064-1668
Rosa-Helena BustosEvidence-Based Therapeutics Group, Department of Clinical Pharmacology, Faculty of Medicine, Universidad de La Sabana, Campus del Puente del Común, Km. 7, Autopista Norte de Bogotá, Chía 250001, Cundinamarca, Colombia.ORCID 0000-0003-0243-2299

Funding

Ministerio de Ciencia, Tecnología e Innovación 123080763958Universidad de La Sabana MED-228-2018
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibodiesantimicrobialantimicrobial resistance (AMR)colistindaptomycinelectrochemical biosensormeropenemsurface plasmon resonance-imaging (SPRi)therapeutic drug monitoring (TDM)vancomycin

Identifiers

PMID42041290
PMCPMC13113538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.